ArticleAnnals of nuclear medicine2026
Diagnostic performance of lung perfusion SPECT/CT using perfusion defect and decrease criteria: a comparative study with CTPA in pulmonary thromboembolism.
Article in Annals of nuclear medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aimed to evaluate the diagnostic performance of lung perfusion SPECT/CT using different interpretation criteria and compare it with computed tomography pulmonary angiography (CTPA) in patients with suspected pulmonary thromboembolism (PTE).
methodsWe retrospectively reviewed 38 patients who underwent both lung perfusion SPECT/CT and CTPA within one week. SPECT/CT images were interpreted using two criteria: a stringent criterion that considered only definite perfusion defects, and a broad criterion that included both definite defects and areas of decreased perfusion. CTPA images were assessed for the presence of filling defects in pulmonary arteries. Final diagnosis of PTE was determined by the treating physician based on clinical, laboratory, and imaging findings, including response to therapy.
resultsCTPA showed a sensitivity of 77.3%, specificity of 81.3%, and overall accuracy of 79.0%. Using the stringent criterion, SPECT/CT showed a sensitivity of 81.8%, specificity of 68.8%, and accuracy of 76.3%. The broad criterion increased sensitivity to 100.0% and negative predictive value, but specificity dropped to 31.3%, with overall accuracy of 71.1%. Among the two SPECT criteria, the stringent approach demonstrated a more balanced diagnostic performance.
conclusionsThe diagnostic performance of lung perfusion SPECT/CT varies depending on the interpretation criteria used. While the broad criterion maximizes sensitivity, the stringent criterion offers more balanced diagnostic accuracy and may serve as a practical alternative when CTPA is contraindicated.
Indexed as
Identifiers
41442015What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.